These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23861789)

  • 1. Wildtype and A30P mutant alpha-synuclein form different fibril structures.
    Nielsen SB; Macchi F; Raccosta S; Langkilde AE; Giehm L; Kyrsting A; Svane AS; Manno M; Christiansen G; Nielsen NC; Oddershede L; Vestergaard B; Otzen DE
    PLoS One; 2013; 8(7):e67713. PubMed ID: 23861789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of α-Synuclein Amyloid Fibrils Using the Fluorescent Probe Thioflavin T.
    Sulatskaya AI; Rodina NP; Sulatsky MI; Povarova OI; Antifeeva IA; Kuznetsova IM; Turoverov KK
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity.
    Murata T; Tochio N; Utsunomiya-Tate N
    Neurosci Lett; 2021 Aug; 760():136077. PubMed ID: 34161822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant protein A30P α-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics.
    Lemkau LR; Comellas G; Kloepper KD; Woods WS; George JM; Rienstra CM
    J Biol Chem; 2012 Mar; 287(14):11526-32. PubMed ID: 22334684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Japanese mutant Aβ (ΔE22-Aβ(1-39)) forms fibrils instantaneously, with low-thioflavin T fluorescence: seeding of wild-type Aβ(1-40) into atypical fibrils by ΔE22-Aβ(1-39).
    Cloe AL; Orgel JP; Sachleben JR; Tycko R; Meredith SC
    Biochemistry; 2011 Mar; 50(12):2026-39. PubMed ID: 21291268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the extent of structural heterogeneity in α-synuclein fibrils by the small molecule thioflavin T.
    Kumar H; Singh J; Kumari P; Udgaonkar JB
    J Biol Chem; 2017 Oct; 292(41):16891-16903. PubMed ID: 28760825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway.
    Giehm L; Oliveira CL; Christiansen G; Pedersen JS; Otzen DE
    J Mol Biol; 2010 Aug; 401(1):115-33. PubMed ID: 20540950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein and familial variants affect the chain order and the thermotropic phase behavior of anionic lipid vesicles.
    Pantusa M; Vad B; Lillelund O; Kjær L; Otzen D; Bartucci R
    Biochim Biophys Acta; 2016 Sep; 1864(9):1206-1214. PubMed ID: 27177693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein aggregation at low concentrations.
    Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorus-containing dendrimers against α-synuclein fibril formation.
    Milowska K; Gabryelak T; Bryszewska M; Caminade AM; Majoral JP
    Int J Biol Macromol; 2012 May; 50(4):1138-43. PubMed ID: 22353396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early sodium dodecyl sulfate induced collapse of α-synuclein correlates with its amyloid formation.
    Basak S; Prasad GV; Varkey J; Chattopadhyay K
    ACS Chem Neurosci; 2015 Feb; 6(2):239-46. PubMed ID: 25369246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study.
    Curtain CC; Kirby NM; Mertens HD; Barnham KJ; Knott RB; Masters CL; Cappai R; Rekas A; Kenche VB; Ryan T
    Mol Biosyst; 2015 Jan; 11(1):190-6. PubMed ID: 25352253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative characterization of protein nanostructures using atomic force microscopy.
    Segers-Nolten I; van der Werf K; van Raaij M; Subramaniam V
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():6609-12. PubMed ID: 18003540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J; Uversky VN; Fink AL
    Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation.
    Liu Y; Carver JA; Calabrese AN; Pukala TL
    Biochim Biophys Acta; 2014 Sep; 1844(9):1481-5. PubMed ID: 24769497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibril breaking accelerates α-synuclein fibrillization.
    Shvadchak VV; Claessens MM; Subramaniam V
    J Phys Chem B; 2015 Feb; 119(5):1912-8. PubMed ID: 25582977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.
    Conway KA; Lee SJ; Rochet JC; Ding TT; Williamson RE; Lansbury PT
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):571-6. PubMed ID: 10639120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
    Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
    J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
    Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
    ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T.
    Li J; Uversky VN; Fink AL
    Neurotoxicology; 2002 Oct; 23(4-5):553-67. PubMed ID: 12428728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.